《新股消息》LFG投資控股(03938.HK)今起招股 入場費3,434元
香港金融服務供應商LFG投資控股(03938.HK)公布,計劃總發行7,200萬股股份,當中國際配售佔90%,香港公開發售為10%。公開招股期自今日(17日)至周五(20日)中午,每股招股價1.3至1.7元,每手2,000股,入場費為3,434.26元。股份預計於9月30日掛牌。聯席保薦人力高企業及TUS Corpoorate。
公司集資用途包括,約60.9%用於擴展包銷業務;約13.6%用於成立資產管理業務下的新基金的種子基金;約9.1%為擴大證券融資業務而增加資本基礎;約6.4%用於透過招聘最多六名新員工;以及約10%用作營運資金需求及一般企業用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.